Hematopathology

(H001) Validation of NGS-Based TCR Gamma and Beta Clonality Assay Using Institutional Interpretation Guidelines and Comparison to Published Criteria

(H002) B-Cell Clonality Testing by NGS: Weighing the Importance of Polyclonal Background Versus Read Percentage in Borderline Cases

(H003) Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing

(H004) Detection of MYD88 L265P Mutation in Circulating Tumor DNA from Cerebrospinal Fluid for Primary Central Nervous System Lymphoma Diagnosis: A Systematic Review and Meta-Analysis

(H005) Validation and Implementation of B-cell Acute Lymphoblastic Leukemia (B-ALL) Subtype Classification by RNA Sequencing (RNA-Seq) Gene Expression Profiling

(H006) Diversity-Informed Adaptive Thresholds for Clonal Abundance in T-Cell Receptor Repertoire Characterization

(H007) Exploring the Genetic Profile of TPMT and NUDT15 in Pediatric B-Cell Acute Lymphoblastic Leukemia in Mexico

(H008) Improved Detection of Vitreoretinal Lymphoma and Higher Disease Burden within Cell-Free Component of Ocular Specimens Based on MYD88 L265P Analysis

(H009) Improved Genomic Diagnostics for Prognostication in Multiple Myeloma Using Myeloma-Focused Optical Genome Mapping and Next-Generation Sequencing

(H010) Validation of Optical Genome Mapping for diagnosis of lymphoid malignancies

(H011) Microsatellite Instability in Immunocompetent B-Cell Lymphomas: A Molecular and Mutational Signature Analysis of MSI-High Cases

(H012) Potential Role of cfDNA in Diffuse Large B cell Lymphoma

(H013) Prevalence of Gene Fusions in Mexican Pediatric B-Cell Acute Lymphoblastic Leukemia Patients

(H014) Retrospective Analysis of Paired Tumor/Normal Sequencing and Its Clinical Utility in Pediatric B-Cell Acute Lymphoblastic Leukemia

(H015) RNA Expression Characterization of T-cell Receptor Gene Rearrangements in patients with T cell malignancies

(H016) Title: Diversity-Informed Adaptive Threshold Framework for T-Cell Receptor DNA Repertoire Analysis

(H017) Clinically Relevant Somatic Copy Number Variation and Gene Fusion Detection via Targeted NGS: A Diagnostic Tool for Hematolymphoid Malignancies

(H018) Co-Existence of SF3B1 With Other Splicing Factor Mutations in Myeloid Neoplasms: Patterns of Mutation Hotspots and Clonal Progression

(H019) Best Practices for the Detection, Interpretation, and Reporting of In Cis Variants in AML

(H020) DDX41-Associated Neoplasia in Clinical Practice: Insights from a Single-Institution Initial Cohort

(H021) Beyond JAK2: Genomics-Driven Diagnosis and a Case for NGS-First in Indian MPNs: Diagnostic and Economic Superiority of an NGS-First Approach

(H022) Diagnostic Challenges in Identifying Suitable CAR-T Targets in AML

(H023) Clinical Utility of ddPCR-Based MRD Monitoring in inv(16) AML: A Single-Center Experience from a tertiary Cancer Care Center in Eastern India.

(H024) Molecular Profile Characteristics of Myeloid Neoplasms Containing Spliceosome Mutations

(H025) Comparing the Clinical Utility of Rapid Amplicon-Based Versus Comprehensive Hybrid-Capture NGS Testing in Myeloid Malignancies

(H026) The Emerging Role of IKZF1 in Myeloid Neoplasms

(H027) Comparison of Digital and Conventional Real-Time Quantitative PCR for BCR::ABL1 Monitoring in Chronic Myeloid Leukemia Patients

(H028) Addition of a Targeted Gene Fusion Assay into Myeloid NGS Enables Detection of Cytogenetically Cryptic, Disease-Defining AML Gene Fusions

(H029) Impact of reclassification and subcategorization of variants of uncertain significance in Acute Myeloid Leukemia

(H030) Clinical Validation of a Targeted RNA Sequencing Panel for Gene Fusions and Select Relative Gene Expression in Hematologic Malignancies

(H031) Relapse-associated somatic mutation changes in acute myeloid leukemia post allogenic hematopoietic cell transplantation

(H032) Evaluation of In-House Next-Generation Sequencing versus Send-Out Sanger Sequencing for CEBPA Mutations in Acute Myeloid Leukemia

(H034) Myeloid Cell SORTing for Improved NGS Interpretation (“MySORT”): A Pilot Investigation of Cell Sorting to Distinguish Somatic and Germline Variants Detected by a Clinical Myeloid NGS Panel

(H035) Validation and clinical utility of a rapid qPCR assay in detecting IDH1 and IDH2 mutations in Acute Myeloid Leukemia patients

(H036) Simple yet Effective Tumor Cell Fraction Measurement in Acute Myeloid Leukemia (AML) Samples using Next Generation Sequencing.

(H037) A Comparison Of Multi-Dimensional Flow Cytometry Vs. High Sensitivity Sequencing For The Detection Of Persistent Disease In AML And MDS Patients

(H038) Utility of Peripheral Blood Genetic Testing in the work up of idiopathic Chronic Cytopenia in Adults to identify Myeloid Disorders

(H039) A Rapid Acute Leukemia Targeted Next Generation Sequencing Panel with a Short Turnaround Time

(H040) Comparison of leukemia-associated fusion detection between next-generation sequencing RNAseq and FISH

(H041) Development of a Rapid Whole Genome Sequencing Assay for Diagnosis of Acute Myeloid Leukemia

(H042) Development of Large Panel Hybrid Capture-Based Duplex Sequencing Assay for Monitoring Minimal Residual Disease in Pediatric Acute Myeloid Leukemia

(H043) Diagnostic Utility of Exome Based Genomic Copy Number Events in Hematological Malignancies

(H044) Diagnostic Yield of Clinical Whole Exome Sequencing of Lymphoma for Mutations and Copy Number Variations

(H045) Evaluation of Monitoring Linearity of Quantitative Measurement of Oncology Assays with Synthetic Linearity Panels

(H046) Expanding Access to the QuantideX qPCR BCR-ABL IS Kit Through Validation on Multiple Quantitative Real-Time Instruments

(H047) FLT3 ITD Detection Using a Deep Sequencing NGS Assay is Sensitive for Measuring Residual Disease in AML

(H048) Introduction of a Rapid AML Panel into the molecular laboratory workflow.

(H049) KMT2A Fusion Detection for Measurable Residual Disease in Acute Myeloid Leukemia Using a Novel Multiplex Digital PCR Assay

(H050) Limited prognostic implications of newly defined entities of myelodysplastic neoplasms by WHO 2022 and ICC

(H051) Multi-Institutional FFPE Sample Validation of a 76-Gene Myeloid NGS Panel

(H053) Performance Evaluation of the Maxwell RSC Whole Blood DNA Kit for NGS-Based Diagnostic Testing of Hematologic Malignancies

(H054) Prospective Nationwide Evaluation of Whole Genome Sequencing for Acute Myeloid Leukemia

(H055) Types and Assessment of Non-canonical FLT3 Juxtamembrane Domain Variants in Patients With Acute Myeloid Leukemia

(H056) Validation of Next-Generation Sequencing Panel for Hematologic Malignancies Using GOAL Consortium Probes

(H057) Validation of Single Channel ddPCR-based UBA1 Mutation Detection for VEXAS Syndrome: Navigating Interference for Mutation Ascertainment

(H058) DNA-based immune cell quantification with methylation cytometry is equivalent to clinical flow cytometry and CBC differential

(H059) Emergence of TP53 Mutations in Myeloproliferative Neoplasms: A Snapshot of the Genetic Landscape at Clonal Evolution

(H060) Validation of NGS on Bone Marrow Mononuclear Cells and CD138 selected cells in patients with Monoclonal Gammopathy of Unknown Significance and Smoldering Multiple Myeloma with Risk of AL Amyloidosis

(H061) Hemoglobin Sallanches (HBA2:c.314G>A): Clinical and Molecular Characterization of 41 Cases Reveals Diagnostic Challenges and Genotype-Phenotype Trends in an Uncommon α-Thalassemia Variant

(H062) Optical genome mapping unravels cryptic rearrangements in acute leukemias

(H063) Ordering Patterns and Results of a Next-Gen Sequencing Panel for Myeloproliferative Neoplasms

(H064) Single -Tube, Single-Molecule Quantification of BCR-ABL Fusions via PCR-based RNA Counting

(H066) Triaging NGS Orders to Prevent Duplicate Testing

(H067) Validation of a Patient-centric Collection Technology for ddPCR Detection of the KIT D816V mutation

(H068) Race Against the Clock: Validating a Rapid NGS Myeloid Panel

(H069) Evaluation of oncoReveal MPN Panel on Illumina Miseq i100 for Driver Mutation Testing in Myeloproliferative Neoplasms